These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19460658)

  • 1. Familial risk for common diseases in primary care: the Family Healthware Impact Trial.
    O'Neill SM; Rubinstein WS; Wang C; Yoon PW; Acheson LS; Rothrock N; Starzyk EJ; Beaumont JL; Galliher JM; Ruffin MT;
    Am J Prev Med; 2009 Jun; 36(6):506-14. PubMed ID: 19460658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial.
    Acheson LS; Wang C; Zyzanski SJ; Lynn A; Ruffin MT; Gramling R; Rubinstein WS; O'Neill SM; Nease DE;
    Genet Med; 2010 Apr; 12(4):212-8. PubMed ID: 20216073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family history assessment: impact on disease risk perceptions.
    Wang C; Sen A; Ruffin MT; Nease DE; Gramling R; Acheson LS; O'Neill SM; Rubinstein WS;
    Am J Prev Med; 2012 Oct; 43(4):392-8. PubMed ID: 22992357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.
    Rubinstein WS; Acheson LS; O'Neill SM; Ruffin MT; Wang C; Beaumont JL; Rothrock N;
    Genet Med; 2011 Nov; 13(11):956-65. PubMed ID: 22075527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial.
    Ruffin MT; Nease DE; Sen A; Pace WD; Wang C; Acheson LS; Rubinstein WS; O'Neill S; Gramling R;
    Ann Fam Med; 2011; 9(1):3-11. PubMed ID: 21242555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Family Healthware, a family history screening tool to prevent common chronic diseases.
    Yoon PW; Scheuner MT; Jorgensen C; Khoury MJ
    Prev Chronic Dis; 2009 Jan; 6(1):A33. PubMed ID: 19080039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.
    Hughes KS; Roche C; Campbell CT; Siegel N; Salisbury L; Chekos A; Katz MS; Edell E
    Breast J; 2003; 9(1):19-25. PubMed ID: 12558666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey.
    Scheuner MT; McNeel TS; Freedman AN
    Genet Med; 2010 Nov; 12(11):726-35. PubMed ID: 20921897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population.
    Wallace E; Hinds A; Campbell H; Mackay J; Cetnarskyj R; Porteous ME
    Br J Cancer; 2004 Oct; 91(8):1575-9. PubMed ID: 15381929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care.
    Walter FM; Prevost AT; Birt L; Grehan N; Restarick K; Morris HC; Sutton S; Rose P; Downing S; Emery JD
    Br J Gen Pract; 2013 Jun; 63(611):e393-400. PubMed ID: 23735410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial.
    Wu RR; Orlando LA; Himmel TL; Buchanan AH; Powell KP; Hauser ER; Agbaje AB; Henrich VC; Ginsburg GS
    BMC Fam Pract; 2013 Aug; 14():111. PubMed ID: 23915256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prompting Primary Care Providers about Increased Patient Risk As a Result of Family History: Does It Work?
    Zazove P; Plegue MA; Uhlmann WR; Ruffin MT
    J Am Board Fam Med; 2015; 28(3):334-42. PubMed ID: 25957366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
    JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial.
    Watson E; Clements A; Yudkin P; Rose P; Bukach C; Mackay J; Lucassen A; Austoker J
    Br J Gen Pract; 2001 Oct; 51(471):817-21. PubMed ID: 11677705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention.
    Ramsey SD; Yoon P; Moonesinghe R; Khoury MJ
    Genet Med; 2006 Sep; 8(9):571-5. PubMed ID: 16980813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol.
    Qureshi N; Armstrong S; Saukko P; Sach T; Middlemass J; Evans PH; Kai J; Farrimond H; Humphries SE
    BMC Health Serv Res; 2009 Oct; 9():184. PubMed ID: 19821989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing family history of chronic disease in primary care: Prevalence, documentation, and appropriate screening.
    Carroll JC; Campbell-Scherer D; Permaul JA; Myers J; Manca DP; Meaney C; Moineddin R; Grunfeld E
    Can Fam Physician; 2017 Jan; 63(1):e58-e67. PubMed ID: 28115461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological impact of family history risk assessment in primary care: a mixed methods study.
    Birt L; Emery JD; Prevost AT; Sutton S; Walter FM
    Fam Pract; 2014 Aug; 31(4):409-18. PubMed ID: 24728773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.